Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies
Authors:
- Yafang LiYLYafang Li
- Xiangjun XiaoXXXiangjun Xiao
- Jianrong LiJLJianrong Li
- Younghun HanYHYounghun Han
- Chao ChengCCChao Cheng
- Gail F. FernandesGFGail F. Fernandes
- Shannon E. SlewitzkeSSShannon E. Slewitzke
- Susan M. RosenbergSRSusan M. Rosenberg
- Meng ZhuMZMeng Zhu
- Jinyoung ByunJBJinyoung Byun
- Yohan BosséYBYohan Bossé
- James D. McKayJMJames D. McKay
Open Access
- 5 January 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (3) , 389-399
Abstract
Background: Clinical, molecular, and genetic epidemiology studies displayed remarkable differences between ever- and never-smoking lung cancer. Methods: We conducted a stratified multi-population (European, East Asian, and African descent) association study on 44,823 ever-smokers and 20,074 never-smokers to identify novel variants that were missed in the non-stratified analysis. Functional analysis including expression quantitative trait loci (eQTL) colocalization and DNA damage assays, and annotation studies were conducted to evaluate the functional roles of the variants. We further evaluated the impact of smoking quantity on lung cancer risk for the variants associated with ever-smoking lung cancer. Results: Five novel independent loci, GABRA4, intergenic region 12q24.33, LRRC4C, LINC01088, and LCNL1 were identified with the association at two or three populations (P < 5 × 10−8). Further functional analysis provided multiple lines of evidence suggesting the variants affect lung cancer risk through excessive DNA damage (GABRA4) or cis-regulation of gene expression (LCNL1). The risk of variants from 12 independent regions, including the well-known CHRNA5, associated with ever-smoking lung cancer was evaluated for never-smokers, light-smokers (packyear ≤ 20), and moderate-to-heavy-smokers (packyear > 20). Different risk patterns were observed for the variants among the different groups by smoking behavior. Conclusions: We identified novel variants associated with lung cancer in only ever- or never-smoking groups that were missed by prior main-effect association studies. Impact: Our study highlights the genetic heterogeneity between ever- and never-smoking lung cancer and provides etiologic insights into the complicated genetic architecture of this deadly cancer.Keywords
All Related Versions
Funding Information
- National Cancer Institute (U19-CA203654)
- Cancer Prevention and Research Institute of Texas (RR170048)
- National Cancer Institute (R21CA235464)
This publication has 31 references indexed in Scilit:
- RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell ProliferationMolecular Cell, 2013
- Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in AsiaNature Genetics, 2012
- Annotation of functional variation in personal genomes using RegulomeDBGenome Research, 2012
- Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry—A Meta‐Analysis of Chromosome 15q25Genetic Epidemiology, 2012
- Variants in Inflammation Genes Are Implicated in Risk of Lung Cancer in Never Smokers Exposed to Second-hand SmokeCancer Discovery, 2011
- Subnuclear targeting of the RNA-binding motif protein RBM6 to splicing speckles and nascent transcriptsChromosome Research, 2010
- Smoking and Lung Cancer: The Role of InflammationProceedings of the American Thoracic Society, 2008
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Nature Genetics, 2008
- Novel genes identified in a high-density genome wide association study for nicotine dependenceHuman Molecular Genetics, 2006
- High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.2000